Stock Price Quote

SYNCOM FORMULATIONS (INDIA) LTD.

NSE : NABSE : 524470ISIN CODE : INE312C01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.16-0.06 (-1.86 %)
PREV CLOSE ( ) 3.22
OPEN PRICE ( ) 3.16
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3.16 (1247635)
VOLUME 232597
TODAY'S LOW / HIGH ( )3.16 3.16
52 WK LOW / HIGH ( ) 0.394
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 21-06 1988
Management Info
Kedarmal Bankda - Chairman Vijay Shankarlal Bankda - Managing Director
Registered Office

Address 7 Niraj Industrial Estate,Off Mahakali Caves Road,Andheri (E),
Mumbai,
Maharashtra-400093

Phone 022 2687 7700 / 11

Email finance@sfil.in

Website www.sfil.in

Registrars Details
Ankit Consultancy Pvt Ltd
Plot No 60,Electronic Complex,Pardeshipura,Indore
Listing : BSE

NEWS

20Jan Allotment of Convertible warrants
Inter alia, to consider and approve : 1. To consider and allot upto 15,..
18Jan Syncom Formulations India trades in gr
Syncom Formulations (India) is currently trading at Rs. 3.69, up by 0.04..
16Jan Syncom Formulations India awarded by I
Syncom Formulations (India) has been awarded by IPF Industrial Excellenc..
14Jan Outcome Of EGM
Outcome of the 1/2020-21 Extra Ordinary General Meeting of the Company h..
14Jan Scrutinizer''''s Report
With reference to the captioned subject, we hereby submit the results of..

Financials

in Millions
QTR Sep 20 ANNUAL 20
Net Profit92.36142.53
Gross Profit 125.32 172.89
Operating Profit 135.79218.62
Net Sales 658.532055.11

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Hester Biosciences (BSE)
peergroup  1670.85 (1.25%)
M.Cap ( in Cr)1421.37
Ajanta Pharma (BSE)
peergroup  1751.40 (0.98%)
M.Cap ( in Cr)15113.64
Orchid Pharma (BSE)
peergroup  318.00 (4.99%)
M.Cap ( in Cr)1297.96
Jenburkt Pharma (BSE)
peergroup  414.00 (3.18%)
M.Cap ( in Cr)190.00
Natco Pharma (BSE)
peergroup  895.40 (1.20%)
M.Cap ( in Cr)16316.24

Shareholding Pattern

NON-INSTITUTION 59.52%
PROMOTERS 40.48%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd. was incorporated in the year 1988. Its today's share price is 3.22. Its current market capitalisation stands at Rs 246.69 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2055.11 Cr and Total Income of Rs.2107.33 Cr. The company's management includes Praveen Jindal, Vinod Kumar Kabra, Krishna Das Neema, Rinki Bankda, Vijay Shankarlal Bankda, Kedarmal Bankda.

It is listed on the BSE with a BSE Code of 524470 , NSE with an NSE Symbol of and ISIN of INE312C01025. It's Registered office is at 7 Niraj Industrial Estate,Off Mahakali Caves Road,Andheri (E)Mumbai-400093, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Sanjay Mehta & Associates, SP Moondra & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)